US EditionInside The Rampant Sarah Huckabee Sanders Ozempic Rumors - Nicki Swift
- Todd Engel sued Novo Nordisk yesterday in a New Jersey court, claiming Ozempic caused his permanent vision loss.
- The suit alleges he developed non-arteritic anterior ischaemic optic neuropathy after beginning Ozempic treatment for diabetes.
- Engel's attorneys report he is legally blind, forcing him to resign his job and lose the ability to drive.
- The lawsuit pursues relief on nine liability counts and points to studies suggesting a link, despite some thin evidence.
- This latest action adds to similar coordinated lawsuits reflecting increasing concern for Novo Nordisk over NAION allegations.
12 Articles
12 Articles
Court Ruling Limits Ozempic Copies in Favor of FDA, Novo Nordisk
A federal court in Texas has ruled against a trade group representing compounding pharmacies, siding with the Food and Drug Administration (FDA) and pharmaceutical company Novo Nordisk in a dispute over copies of the popular weight-loss and diabetes drugs Ozempic and Wegovy. The ruling, issued April 24 in the U.S. District Court for the Northern District of Texas, denied a request from the Outsourcing Facilities Association (OFA) to block the FD…
Court Ruling Limits Ozempic Copies in Favor of FDA, Novo Nordisk - The Thinking Conservative
Federal court ruled against trade group representing compounding pharmacies, siding with FDA and Novo Nordisk in dispute over copies of Ozempic and Wegovy. The post Court Ruling Limits Ozempic Copies in Favor of FDA, Novo Nordisk appeared first on The Thinking Conservative.
Ozempic Lawsuit: Diabetes Patient Claims Blindness – Archyde
Archyde “`html Ozempic Lawsuit: Blindness Claims Raise Concerns Maryland Man Sues ozempic Manufacturer, Alleging Drug-Induced Blindness A lawsuit filed in New Jersey claims Novo nordisk failed to warn patients about the risk of vision loss linked to its popular diabetes and weight-loss drug. May 1, 2025 A Maryland man who took Ozempic to manage his Type […] You can read the full story here: Ozempic Lawsuit: Diabetes Patient Claims Blindness.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
